GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states.
about
Postprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions.Role of the Enterocyte in Fructose-Induced HypertriglyceridaemiaSitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans.Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetesGlucagon-like peptide-2 regulates release of chylomicrons from the intestine.Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitorsMinor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.Glucagon receptor antagonism induces increased cholesterol absorption.Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetesThe role of gastrointestinal hormones in hepatic lipid metabolism.The pathophysiology of intestinal lipoprotein production.The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?Control of chylomicron export from the intestine.Social housing and social isolation: Impact on stress indices and energy balance in male and female Syrian hamsters (Mesocricetus auratus).Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.It's all in your gut and mind.Effective cryopreservation of golden Syrian hamster embryos by open pulled straw vitrification.Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes.Generation of transgenic golden Syrian hamsters.GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.Genomic organization and expression of immunoglobulin genes in the Chinese hamster (Cricetulus griseus).Chylomicrons stimulate incretin secretion in mouse and human cells.Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2.Effects of a diet rich in arabinoxylan and resistant starch compared with a diet rich in refined carbohydrates on postprandial metabolism and features of the metabolic syndrome.Apolipoprotein E (epsilon) genotype has a greater impact on apoB-48 than apoB-100 responses to dietary fat manipulation-insights from the SATgenε study.Influence of endogenous glucagon-like peptide-2 on lipid disorders in mice fed a high-fat diet.
P2860
Q30362026-EFD21CAE-83E8-4B9C-8AF3-0591DA70EF8FQ33616687-28C7A142-3514-4FD2-B3F5-ED149898C382Q33789371-450F2052-37B9-4D09-8614-CFADF7437D8BQ34994502-5435D785-63DA-4810-B0B9-DEE3808A0E01Q35046115-951525BD-D294-4598-A4CB-FBA8FA99C3C0Q35624667-8B480D95-D47B-41B7-ACA5-9AD609850F9CQ35890612-7C884B9D-A25D-4943-B2CF-D50878C0F670Q36197864-A574ABC5-6680-45E4-9ECA-6C61E7930074Q36607551-1337799F-E885-4360-999E-CD981F376EABQ37640700-D3F55958-EA65-49B5-9742-C97DB6B74762Q38410893-10412360-13DE-4C15-A543-88D83FCD09B3Q38527885-57738A9E-F3B6-45F0-8539-777AE48F64B4Q38763876-85353DF5-F84C-4D7A-8583-5EA8CE4F0F89Q38782099-D66610D6-056C-4978-BB31-AD484E543D11Q38923365-F2DDBBCE-49CE-447F-B831-43A3D953EA02Q40096427-306FFEC0-EBD4-4A28-8928-A036C13E9685Q41601206-F51AEBB2-5F62-4D4B-B973-D9FD5C57DBEFQ41886525-470F47BE-2C48-414E-ACD9-8FAFDAF87EFDQ42418999-B0316EAE-6D07-4309-A6C2-DDD0B46FEB40Q42582553-07BA336F-7DC9-4C80-AEF3-6E4316390360Q42635500-790A7BCD-2DB5-448C-B27C-FE1C069990F1Q44979797-D6C0CBD5-13BA-431E-9A62-3269499D4350Q46312766-ACD60EDC-B8E8-4C40-9418-C89E630099EDQ49926115-34693A1E-E64E-4D46-B066-BBA6BA40B4CAQ51274019-8029350D-691D-4370-AB40-B2DC7C659492Q51275295-F022C0C1-93FD-4DA3-9AF5-6B6E025C8A1FQ53796021-6B6E720C-C537-49FF-9000-8060214CDC40
P2860
GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
GLP-1 and GLP-2 as yin and yan ...... and insulin-resistant states.
@en
type
label
GLP-1 and GLP-2 as yin and yan ...... and insulin-resistant states.
@en
prefLabel
GLP-1 and GLP-2 as yin and yan ...... and insulin-resistant states.
@en
P2093
P2860
P356
P1433
P1476
GLP-1 and GLP-2 as yin and yan ...... l and insulin-resistant states
@en
P2093
Chris Baker
Joanne Hsieh
Khosrow Adeli
Sarah Farr
P2860
P304
P356
10.2337/DB12-0202
P407
P50
P577
2012-10-01T00:00:00Z